A carregar...
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2018-05-01
|
| Colecção: | Experimental Hematology & Oncology |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s40164-018-0104-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|